Diagnostic and Management Pathways for Pulmonary Carcinoid Tumours in the United Kingdom: Results from the National Lung Neuroendocrine Tumour Pathway Project

Table 3

Reported follow-up frequency and total duration of follow-up in patients with TC and AC after completion of initial treatment.

PC type/stage	Initial follow-up frequency (range between respondents)		Total follow-up duration (range between respondents)
	TC	AC	TC	AC
N0 M0	3–12 months	3–12 months	2–10 years	2–10 years
N1 M0	3–12 months	3–12 months	2–10 years	2–10 years
N2-3 M0	3–12 months	3–12 months	3–10 years	2 years–indefinite
R1 resected	3–12 months	3–12 months	3–10 years	2 years–indefinite
Stage IV	2–12 months	2–12 months	3 years–indefinite	3 years–indefinite

AC: atypical carcinoid; TC: typical carcinoid.